isogenic cell lines | GenomeWeb

isogenic cell lines

Thermo Fisher will market Horizon's X-MAN human haploid and diploid isogenic cell line collection. 

The UK-based firm will provide Sanger with more than 200 genetically defined cell lines with cancer-causing mutations, which will guide researchers working on the Genomics of Drug Sensitivity in Cancer project.

Expanding their relationship, the cancer drug developer will use the mutant-and-normal cell line library.

Horizon will develop X-MAN cancer models for the drug developer's therapeutic research programs.

The partners will use Horizon's cell lines to identify unique protein biomarker signatures.

Cambridge, UK-based Horizon will provide GSK with its isogenic cell lines for cancer metabolomics studies.

The drug developer will use Horizon's X-MAN technology in genotype-specific compound tests.

Horizon Discovery also plans to participate in a consortium of "top academic institutions and big pharmas" in the cancer field, a research partnership expected to expand its panel of isogenic cell lines for drug discovery.

The school aims to develop biomarkers for use in cancer diagnostics.

Horizon will use the genetic modeling technology to develop cancer-related screening products and services.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.